CRISPR, short for Clustered Regularly Interspaced Short Palindromic Repeats, is a groundbreaking gene-editing technology that ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Researchers use CRISPR to overcome seemingly insurmontable reproductive barriers — but that doesn't mean this could work for ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Vertex Pharmaceuticals (VRTX) stock gains as England opts to reimburse its CRSPR (CRSP)-partnered gene therapy Casgevy to ...